Sneha Shah Jain, MD, MBA (@snehashahjain) 's Twitter Profile
Sneha Shah Jain, MD, MBA

@snehashahjain

Cardiologist and Clinical Assistant Professor at Stanford. Hopkins MD, Harvard MBA. Formerly at Moderna Therapeutics and Flare Capital.

ID: 24832166

linkhttp://www.linkedin.com/in/sneha-s-jain calendar_today17-03-2009 03:28:49

392 Tweet

991 Followers

914 Following

Stanford AIMI (@stanfordaimi) 's Twitter Profile Photo

Join us Dec. 10-11 for the 4th annual AI+HEALTH Stanford University! We'll explore real-world #AI applications across healthcare, delivering actionable knowledge & insights. Hosted by #AIMICenter, Stanford HAI & Stanford CME. aiplushealth.stanford.edu

Join us Dec. 10-11 for the 4th annual AI+HEALTH <a href="/Stanford/">Stanford University</a>! We'll explore real-world #AI applications across healthcare, delivering actionable knowledge &amp; insights. Hosted by #AIMICenter, <a href="/StanfordHAI/">Stanford HAI</a> &amp; <a href="/StanfordCME/">Stanford CME</a>. aiplushealth.stanford.edu
Sneha Shah Jain, MD, MBA (@snehashahjain) 's Twitter Profile Photo

Fantastic presentation by Rohan Khera and Greg Holste on PanEcho at the #AHA24. Amit Khera and team piloted a new initiative at #AHA24 to allow co-presentation of late breaking science by both the PI & a junior investigator. What a success!

Fantastic presentation by <a href="/rohan_khera/">Rohan Khera</a> and <a href="/giholste/">Greg Holste</a> on PanEcho at the #AHA24. 

<a href="/dramitkhera/">Amit Khera</a> and team piloted a new initiative at #AHA24 to allow co-presentation of late breaking science by both the PI &amp; a junior investigator. What a success!
Manan Pareek, MD, PhD, FAHA, FESC (@mananpareekmd) 's Twitter Profile Photo

Fantastic #LBCT presentation from Ankeet S. Bhatt, MD, MBA on #fluvaccine among patients w/wo MI in the NUDGE-FLU program: ‘A CV-focused msg strategy should be considered for population-level outreach to improve vax rates in pts with AMI.’ Sim pub in JAMA Cardiology! jamanetwork.com/journals/jamac…

Fantastic #LBCT presentation from <a href="/ankeetbhatt/">Ankeet S. Bhatt, MD, MBA</a> on #fluvaccine among patients w/wo MI in the NUDGE-FLU program:

‘A CV-focused msg strategy should be considered for population-level outreach to improve vax rates in pts with AMI.’

Sim pub in <a href="/JAMACardio/">JAMA Cardiology</a>!

jamanetwork.com/journals/jamac…
Harlan Krumholz (@hmkyale) 's Twitter Profile Photo

🚨 Just published in JACC Journals: C. Michael Gibson MD explores the OCEANIC-AF findings and the ongoing debate on factor XI inhibitors. Are we still in equipoise? #Cardiology #ClinicalTrials #AFib Read the perspective here: buff.ly/3B3uay6

Harlan Krumholz (@hmkyale) 's Twitter Profile Photo

🚀 Published today in JACC Journals: "The Coming AI Revolution in Clinical Trials," co-authored by leading experts Sneha S. Jain euan ashley, Robert Harrington, Kenneth Mahaffey, and Nigam Shah. On how AI is reshaping RCTs! #Cardiology #AI #ClinicalTrials 🔗 buff.ly/4gcXCRD

Morgan Cheatham (@morgancheatham) 's Twitter Profile Photo

in our latest publication in Health, Management, Policy, and Innovation – "Why AI Is Good for Our Health but May Hurt Our Wallets," we examine how current regulatory frameworks, reimbursement structures, and business models for AI in healthcare are decoupled, creating an

in our latest publication in Health, Management, Policy, and Innovation – "Why AI Is Good for Our Health but May Hurt Our Wallets," we examine how current regulatory frameworks, reimbursement structures, and business models for AI in healthcare are decoupled, creating an
CVCT - CardioVascular Clinical Trialists (@cvctforum) 's Twitter Profile Photo

#CVCT2024 : #ArtificialIntelligence has the potential to revolutionize clinical trials in cardiovascular care. Key opportunities include personalized trial designs, streamlined recruitment, and improved data interpretation. However, challenges such as algorithm bias, ethical

#CVCT2024 : #ArtificialIntelligence has the potential to revolutionize clinical trials in cardiovascular care. Key opportunities include personalized trial designs, streamlined recruitment, and improved data interpretation. However, challenges such as algorithm bias, ethical
CVCT - CardioVascular Clinical Trialists (@cvctforum) 's Twitter Profile Photo

Final clap for #CVCT2024 ! Thank you for 3 days of deep scientific discussions, inspiration and friendship ! Now, time for action ! #clinicaltrials #movingforward

Final clap for #CVCT2024 ! Thank you for 3 days of deep scientific discussions, inspiration and friendship ! Now, time for action !
#clinicaltrials #movingforward
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

Our ASPC statement on South Asians & Cardiometabolic Health in AJPC I had the honour of co-chairing this w/ the amazing Anand Rohatgi & Jaideep Thank you to our entire talented team who brought this to life 📎shorturl.at/4bJGz #CVPrev #CardioTwitter

Our <a href="/ASPCardio/">ASPC</a> statement on South Asians &amp; Cardiometabolic Health in <a href="/AJPCardio/">AJPC</a>  
I had the honour of co-chairing this w/ the amazing <a href="/dranandrohatgi/">Anand Rohatgi</a> &amp; <a href="/jaideeppatelmd/">Jaideep</a> 
Thank you to our entire talented team who brought this to life
📎shorturl.at/4bJGz
#CVPrev #CardioTwitter